Detalles de la búsqueda
1.
Design and synthesis of new tetrahydroquinolines derivatives as CETP inhibitors.
Bioorg Med Chem Lett
; 22(11): 3671-5, 2012 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-22543028
2.
N-(4-((2-(trifluoromethyl)-3-hydroxy-4-(isobutyryl)phenoxy)methyl)benzyl)-1-methyl-1H-imidazole-4-carboxamide (THIIC), a novel metabotropic glutamate 2 potentiator with potential anxiolytic/antidepressant properties: in vivo profiling suggests a link between behavioral and central nervous system neurochemical changes.
J Pharmacol Exp Ther
; 336(1): 165-77, 2011 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-20947638
3.
Discovery of the First α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Antagonist Dependent upon Transmembrane AMPA Receptor Regulatory Protein (TARP) γ-8.
J Med Chem
; 59(10): 4753-68, 2016 05 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-27067148
4.
Discovery of (1S,2R,3S,4S,5R,6R)-2-Amino-3-[(3,4-difluorophenyl)sulfanylmethyl]-4-hydroxy-bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid Hydrochloride (LY3020371·HCl): A Potent, Metabotropic Glutamate 2/3 Receptor Antagonist with Antidepressant-Like Activity.
J Med Chem
; 59(24): 10974-10993, 2016 12 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-28002967
5.
Design and synthesis of a potent and selective triazolone-based peroxisome proliferator-activated receptor alpha agonist.
J Med Chem
; 46(24): 5121-4, 2003 Nov 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-14613314
Resultados
1 -
5
de 5
1
Próxima >
>>